Scientists in Galway have found a way of reducing relapses in one of the most aggressive cancers

Scientists in Galway have found a way of reducing relapses in one of the most aggressive cancers
File photo of NUI Galway.

Scientists at NUI Galway have found a new treatment which may help reduce relapse rates in patients with triple negative breast cancer.

This form of breast cancer is one of the most aggressive and difficult to treat, as there are no targeted therapies currently available.

Dr Susan Logue from NUI Galway outlined what the new treatment can do.

She said: "We discovered that triple negative breast cancer cells switch on a particular protein that helps them survive chemotherapy and if we switch this protein off then the chemotherapy is much more effective.

"So the significance of this exciting research is that we have discovered a new approach that reduces treatment and reduces relapse in models of triple negative breast cancer."

This form of the disease accounts for around 15% of all breast cancers diagnosed and occurs more frequently in younger women.

Dr Logue said: "For so long there has been no targetted treatment available for people with triple negative breast cancer and we now have a target that looks really promising in the lab.

"If this holds true in clinical trials, it will mean better treatment, improved survival and less relapse for triple negative breast cancer patients."

More on this topic

Ovarian cancer drug offers hope for men with advanced prostate cancerOvarian cancer drug offers hope for men with advanced prostate cancer

Immersive Read: Open your eyes to cancer and #ExamineYourself. It could save your lifeImmersive Read: Open your eyes to cancer and #ExamineYourself. It could save your life

Examine Yourself: Key fundraising event for Breast Cancer IrelandExamine Yourself: Key fundraising event for Breast Cancer Ireland

Examine Yourself: Why superfoods do not prevent or cure cancerExamine Yourself: Why superfoods do not prevent or cure cancer